Vestal Point Capital, LP Portfolio Holdings

Vestal Point Capital, LP

  • $1.34 Trillion
  • Q2 2024

Vestal Point Capital, LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $1.34 Trillion distributed in 60 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Jazz Pharmaceuticals PLC with a value of $160B, Cytokinetics Inc with a value of $112B, Ascendis Pharma A/S with a value of $102B, Ultragenyx Pharmaceutical Inc. with a value of $74B, and Globus Medical Inc with a value of $61.6B.

Examining the 13F form we can see an increase of $132B in the current position value, from $1.21T to 1.34T.

Vestal Point Capital, LP is based out at New York, NY

Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.34 Trillion
Healthcare: $154 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$6.86B
$160 Billion 11.94% of portfolio
1,500,000
Q2 2024 Added 36.36%
$4.88B
$112 Billion 8.38% of portfolio
2,075,000
Q2 2024 Reduced 3.49%
$7.02B
$102 Billion 7.63% of portfolio
750,000
Q2 2024 Added 42.86%
$3.58B
$74 Billion 5.52% of portfolio
1,800,000
Q2 2024 Added 1,536.36%
$5.76B
$61.6 Billion 4.6% of portfolio
900,000
Q2 2024 Reduced 10.0%
$9.26B
$50.3 Billion 3.75% of portfolio
750,000
Q1 2024 Reduced 16.67%
$21.5B
$49.9 Billion 3.72% of portfolio
350,000
Q2 2024 Added 7.69%
Soleno Therapeutics Inc
-
$49 Billion 3.65% of portfolio
-
Q2 2024 Reduced 4.0%
$12.6B
$39.1 Billion 2.91% of portfolio
925,000
Q2 2024 Added 825.0%
$3.78B
$37.3 Billion 2.78% of portfolio
675,000
Q2 2024 Added 575.0%
$711M
$32 Billion 2.38% of portfolio
2,750,000
Q2 2024 Added 129.17%
$2.27B
$30.4 Billion 2.26% of portfolio
725,000
Q2 2024 New
$172M
$29.6 Billion 2.21% of portfolio
3,250,000
Q2 2024 Added 195.45%
$261M
$27.1 Billion 2.02% of portfolio
2,300,000
Q2 2024 Added 251.15%
$411M
$26.2 Billion 1.95% of portfolio
6,490,000
Q2 2024 New
$313M
$26 Billion 1.94% of portfolio
1,750,000
Q2 2024 New
$3.81B
$24.2 Billion 1.8% of portfolio
300,000
Q2 2024 New
$707M
$22 Billion 1.64% of portfolio
1,830,000
Q2 2024 Reduced 8.5%
Structure Therapeutics Inc
-
$22 Billion 1.64% of portfolio
-
Q2 2024 New
$59.1M
$21.7 Billion 1.62% of portfolio
3,600,000
Q2 2024 Added 37.93%
$274M
$21.3 Billion 1.59% of portfolio
4,750,000
Q2 2024 Added 0.53%
$118B
$20.8 Billion 1.55% of portfolio
500,000
Q2 2024 New
$2.6B
$20.5 Billion 1.53% of portfolio
525,000
Q2 2024 Added 31.25%
Praxis Precision Medicines Inc
-
$18.2 Billion 1.36% of portfolio
-
Q2 2024 Added 109.52%
$1.08B
$17.2 Billion 1.28% of portfolio
1,250,000
Q2 2024 New
$2.6B
$16.9 Billion 1.26% of portfolio
350,000
Q2 2024 Reduced 56.25%
Dianthus Therapeutics Inc
-
$15.5 Billion 1.16% of portfolio
-
Q2 2024 Added 31.87%
Solid Biosciences Inc
-
$15.1 Billion 1.13% of portfolio
-
Q2 2024 Added 157.49%
Lexeo Therapeutics Inc
-
$13.5 Billion 1.0% of portfolio
-
Q2 2024 Added 380.0%
$3.14B
$12.9 Billion 0.96% of portfolio
335,000
Q2 2024 Added 48.89%
$141M
$12.1 Billion 0.9% of portfolio
1,000,000
Q2 2024 New
$3.65B
$11.6 Billion 0.87% of portfolio
500,000
Q2 2024 New
$1.15B
$10.4 Billion 0.78% of portfolio
500,000
Q2 2024 New
$105M
$9.79 Billion 0.73% of portfolio
2,100,000
Q2 2024 New
$759M
$8.01 Billion 0.6% of portfolio
280,000
Q2 2024 Added 250.0%
$26.4B
$8.04 Billion 0.6% of portfolio
100,000
Q2 2024 New
$5.55B
$8.03 Billion 0.6% of portfolio
60,000
Q2 2024 New
$1.49B
$7.94 Billion 0.59% of portfolio
225,000
Q2 2024 New
$167M
$7.19 Billion 0.54% of portfolio
1,160,000
Q2 2024 Added 66.91%
Alto Neuroscience Inc
-
$6.63 Billion 0.49% of portfolio
-
Q2 2024 Added 148.0%
$236M
$6.56 Billion 0.49% of portfolio
2,000,000
Q2 2024 Added 150.0%
$391M
$5.13 Billion 0.38% of portfolio
2,200,000
Q2 2024 Added 62.96%
$34.3M
$4.81 Billion 0.36% of portfolio
6,052,000
Q2 2024 Added 34.49%
$271M
$4.75 Billion 0.35% of portfolio
600,000
Q1 2024 New
$1.76B
$4.46 Billion 0.33% of portfolio
180,000
Q2 2024 Added 38.46%
Zymeworks Inc
-
$3.74 Billion 0.28% of portfolio
-
Q2 2024 New
$99.8M
$3.6 Billion 0.27% of portfolio
1,200,000
Q1 2024 Added 943.48%
$416M
$3.33 Billion 0.25% of portfolio
890,000
Q2 2024 New
$238M
$3.4 Billion 0.25% of portfolio
800,000
Q2 2024 Added 10.34%

Summary

  • Portfolio
  • No. of Stocks 60
  • Current Value $1.34 Trillion
  • Prior Value $1.21 Trillion
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 22 stocks
  • Additional Purchases 28 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email